查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608150

靜脈液市場：按類型、成分、最終用戶分類 - 全球預測 2025-2030

Intravenous Solutions Market by Type (Peripheral Parenteral Nutrition, Total Parenteral Nutrition), Composition Solution (Carbohydrates, Dextran, Heparin & Trace Element), End-users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年靜脈輸液市場規模為137.6億美元，預計2024年將達到149.9億美元，複合年成長率為9.13%，2030年將達253.8億美元。

靜脈輸液是醫療保健的重要組成部分，是將必需的營養物質、藥物和水合作用直接輸送到血液中的一種手段。這種方法確保物質的快速吸收和運輸，促進即時的治療效果。在急診醫學、外科手術、慢性病管理和水化治療等重症加護應用中，靜脈輸液的需求尤其明顯。在醫療保健生態系統中，最終用途包括醫院、門診手術中心和居家照護，每種用途都需要可靠的靜脈注射機制。主要成長動力包括世界人口老化、慢性和急性疾病盛行率上升以及家庭醫療保健的普及。電解質輸液和維生素強化輸液的市場開拓等技術進步將進一步推動市場擴張。治療機會在於擴大門診醫療服務和個人化治療解決方案，並根據患者的獨特需求提供精確劑量。然而，感染風險、嚴格的法規結構和原料價格波動等挑戰是主要阻礙因素。此外，對無菌運輸和儲存基礎設施的需求增加了營運成本，限制了小型製造商的進入。創新領域包括監測患者生命徵象、開發具有感測器的智慧輸液系統以確保準確的流量，以及環保包裝以減少對環境的影響。市場相關人員應考慮投資技術整合，例如用於遠端監控靜脈注射治療的物聯網設備，這可以最佳化治療效果並提高患者的依從性。為了克服現有障礙並引領市場創新，繼續專注於研究和開發，特別是具有成本效益和永續的解決方案非常重要。在臨床需求和新興醫療保健趨勢的推動下，輸液解決方案市場仍然充滿活力。

主要市場統計
基準年[2023] 137.6億美元
預測年份 [2024] 149.9億美元
預測年份 [2030] 253.8億美元
複合年成長率（%） 9.13%

市場動態：快速發展的靜脈液市場的關鍵市場洞察

供需的動態交互作用正在改變靜脈輸液市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 胃腸道疾病、癌症和神經系統疾病等慢性和急性疾病的發生率增加
    • 增加靜脈注射的監管核准
    • 增加製造商之間的策略聯盟以加強產品系列
  • 市場限制因素
    • 維持輸液費用高
  • 市場機會
    • 新興經濟體對靜脈輸液的需求不斷增加
    • 產品改進和新創新可提高患者便利性
    • 靜脈輸注維生素C在結直腸癌患者的實施
  • 市場挑戰
    • 靜脈注射的副作用

波特五力：駕馭靜脈液體市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解靜脈輸液市場的外部影響

外部宏觀環境因素在塑造靜脈液體市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解靜脈輸液市場的競爭狀況

靜脈液體市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣輸液液市場供應商績效評估

FPNV 定位矩陣是評估靜脈輸液市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製靜脈液體市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，靜脈液體市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 胃腸道疾病、癌症和神經系統疾病等慢性和急性疾病的發生率增加
      • 增加靜脈輸液的監管核准
      • 增加製造商之間的策略聯盟以加強產品系列
    • 抑制因素
      • 流體維護成本高
    • 機會
      • 新興經濟體對靜脈輸液的需求增加
      • 為患者提供便利的產品改進和新創新
      • 維生素C滴注在結直腸癌患者的實施
    • 任務
      • 靜脈輸液的副作用
  • 市場區隔分析
    • 類型：不斷成長的營養和代謝需求擴大了全靜脈營養的使用
    • 最終使用者：醫院和診所的需求不斷增加，以滿足廣大病患的需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 靜脈液市場：依類型

  • 周邊靜脈營養
  • 全靜脈營養

第7章 靜脈液體市場構成方案

  • 碳水化合物
  • 聚葡萄糖
  • 肝素和微量元素
  • 腸外脂肪乳劑
  • 單劑量氨基酸溶液
  • 維生素和礦物質

第8章靜脈液體市場：依最終使用者分類

  • 門診手術中心
  • 醫院/診所
  • 長期照護設施
  • 專科診所

第9章 北美、南美靜脈輸液市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太靜脈液體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲靜脈輸液市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Hikma 宣佈在美國發布 COMBOGESIC IV
    • Sanjivani Palantral Limited 與 HAL 合作生產靜脈注射製劑和靜脈注射套件
    • CTMUHB 和 Baxter 合作實現更安全的靜脈輸液
  • 戰略分析和建議

公司名單

  • Ajinomoto Co., Inc.
  • Amanta Healthcare Ltd.
  • Anhui Medipharm Co. Ltd
  • Axa Parenterals Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton, Dickinson and Company
  • Enzymes Pharmaceuticals
  • Eurolife Healthcare Pvt. Ltd.
  • Fresenius SE & Co. KGaA
  • Grifols, SA
  • ICU Medical, Inc.
  • JW Life Science Corporation
  • Lxir Medilabs Pvt. Ltd.
  • Nymak Pharma Ltd.
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited
  • Schwitz Biotech
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Soxa Formulations & Research Pvt. Ltd.
  • Terumo Corporation
  • Trumac Healthcare
  • Varni Corporation
  • Vifor Pharma Management Ltd.
Product Code: MRR-710B1F0AC675

The Intravenous Solutions Market was valued at USD 13.76 billion in 2023, expected to reach USD 14.99 billion in 2024, and is projected to grow at a CAGR of 9.13%, to USD 25.38 billion by 2030.

Intravenous (IV) solutions are a critical component in medical care, serving as a means for delivering essential nutrients, medications, and hydration directly into the bloodstream. This method ensures rapid absorption and transport of substances, facilitating immediate therapeutic effects. The necessity of IV solutions is particularly prominent in emergency medicine, surgeries, chronic illness management, and hydration therapy, among other critical care applications. Within the healthcare ecosystem, the end-use scope extends to hospitals, ambulatory surgical centers, and home care settings, each requiring reliable IV delivery mechanisms. Key growth drivers include an aging global population, rising prevalence of chronic and acute illnesses, and the increasing adoption of home healthcare. Technological advancements, such as the development of electrolyte-infused and vitamin-enriched solutions, further enhance market expansion. Opportunities lie in expanding outpatient care services and individualized treatment solutions with accurate dosing according to patients' specific needs. However, challenges such as the risk of infections, stringent regulatory frameworks, and fluctuating raw material prices pose significant restraints. Additionally, the necessity for sterile transport and storage infrastructure elevates operational costs, limiting entry for small-scale manufacturers. Areas ripe for innovation include the development of smart infusion systems equipped with sensors for monitoring patient vitals and ensuring accurate flow rates, as well as eco-friendly packaging to reduce environmental impact. Market players should consider investing in technological integrations such as Internet of Things (IoT) devices for remote monitoring of intravenous therapies, which can optimize treatment efficacy and enhance patient compliance. Maintaining focus on research and development, particularly around cost-effective and sustainable solutions, will be crucial in overcoming existing barriers and leading market innovations. The market for IV solutions remains dynamic, driven by both clinical needs and emerging healthcare trends.

KEY MARKET STATISTICS
Base Year [2023] USD 13.76 billion
Estimated Year [2024] USD 14.99 billion
Forecast Year [2030] USD 25.38 billion
CAGR (%) 9.13%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous Solutions Market

The Intravenous Solutions Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
    • Increasing Regulatory Approvals for Intravenous Solution Injections
    • Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio
  • Market Restraints
    • High Cost of Maintenance of Fluids
  • Market Opportunities
    • Increase in Demand for Intravenous Solutions from Developing Economies
    • Improvements and New Innovations in the Products for Patient Convenience
    • Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer
  • Market Challenges
    • Side Effects of Intravenous Fluids

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous Solutions Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous Solutions Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous Solutions Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous Solutions Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous Solutions Market

A detailed market share analysis in the Intravenous Solutions Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous Solutions Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous Solutions Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous Solutions Market

A strategic analysis of the Intravenous Solutions Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Solutions Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amanta Healthcare Ltd., Anhui Medipharm Co. Ltd, Axa Parenterals Ltd, B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Enzymes Pharmaceuticals, Eurolife Healthcare Pvt. Ltd., Fresenius SE & Co. KGaA, Grifols, S.A., ICU Medical, Inc., JW Life Science Corporation, Lxir Medilabs Pvt. Ltd., Nymak Pharma Ltd., Otsuka Holdings Co., Ltd., Pfizer Inc., Salius Pharma Private Limited, Schwitz Biotech, Sichuan Kelun Pharmaceutical Co., Ltd., Soxa Formulations & Research Pvt. Ltd., Terumo Corporation, Trumac Healthcare, Varni Corporation, and Vifor Pharma Management Ltd..

Market Segmentation & Coverage

This research report categorizes the Intravenous Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Peripheral Parenteral Nutrition and Total Parenteral Nutrition.
  • Based on Composition Solution, market is studied across Carbohydrates, Dextran, Heparin & Trace Element, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, and Vitamins & Minerals.
  • Based on End-users, market is studied across Ambulatory Surgical Centers, Hospitals & Clinics, Long-term Care Facilities, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
      • 5.1.1.2. Increasing Regulatory Approvals for Intravenous Solution Injections
      • 5.1.1.3. Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Maintenance of Fluids
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in Demand for Intravenous Solutions from Developing Economies
      • 5.1.3.2. Improvements and New Innovations in the Products for Patient Convenience
      • 5.1.3.3. Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects of Intravenous Fluids
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs
    • 5.2.2. End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intravenous Solutions Market, by Type

  • 6.1. Introduction
  • 6.2. Peripheral Parenteral Nutrition
  • 6.3. Total Parenteral Nutrition

7. Intravenous Solutions Market, by Composition Solution

  • 7.1. Introduction
  • 7.2. Carbohydrates
  • 7.3. Dextran
  • 7.4. Heparin & Trace Element
  • 7.5. Parenteral Lipid Emulsion
  • 7.6. Single Dose Amino Acid Solution
  • 7.7. Vitamins & Minerals

8. Intravenous Solutions Market, by End-users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals & Clinics
  • 8.4. Long-term Care Facilities
  • 8.5. Specialty Clinics

9. Americas Intravenous Solutions Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intravenous Solutions Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intravenous Solutions Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Hikma announces US launch of COMBOGESIC IV
    • 12.3.2. Sanjivani Paranteral Limited and HAL collaborate to manufacture IV formulations and IV Sets
    • 12.3.3. CTMUHB and Baxter partner to implement safer IV fluid administration
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ajinomoto Co., Inc.
  • 2. Amanta Healthcare Ltd.
  • 3. Anhui Medipharm Co. Ltd
  • 4. Axa Parenterals Ltd
  • 5. B. Braun Melsungen AG
  • 6. Baxter International Inc
  • 7. Becton, Dickinson and Company
  • 8. Enzymes Pharmaceuticals
  • 9. Eurolife Healthcare Pvt. Ltd.
  • 10. Fresenius SE & Co. KGaA
  • 11. Grifols, S.A.
  • 12. ICU Medical, Inc.
  • 13. JW Life Science Corporation
  • 14. Lxir Medilabs Pvt. Ltd.
  • 15. Nymak Pharma Ltd.
  • 16. Otsuka Holdings Co., Ltd.
  • 17. Pfizer Inc.
  • 18. Salius Pharma Private Limited
  • 19. Schwitz Biotech
  • 20. Sichuan Kelun Pharmaceutical Co., Ltd.
  • 21. Soxa Formulations & Research Pvt. Ltd.
  • 22. Terumo Corporation
  • 23. Trumac Healthcare
  • 24. Varni Corporation
  • 25. Vifor Pharma Management Ltd.

LIST OF FIGURES

  • FIGURE 1. INTRAVENOUS SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAVENOUS SOLUTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAVENOUS SOLUTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 149. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023